Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroinflammatory history results in overlapping transcriptional signatures with heroin exposure in the nucleus accumbens and alters responsiveness to heroin in male rats.

Translational psychiatry·2024
Same author

Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats.

Molecular psychiatry·2024
Same author

Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats.

bioRxiv : the preprint server for biology·2024
Same author

Orbitofrontal intronic circular RNA from Nrxn3 mediates reward learning and motivation for reward.

Progress in neurobiology·2023
Same author

Orbitofrontal cortex microRNAs support long-lasting heroin seeking behavior in male rats.

Translational psychiatry·2023
Same author

microRNA expression levels in the nucleus accumbens correlate with morphine-taking but not morphine-seeking behaviour in male rats.

The European journal of neuroscience·2022

Related Experiment Video

Updated: Jun 25, 2025

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.2K

Morphine-Driven m6A Epitranscriptomic Neuroadaptations in Primary Cortical Cultures.

Konrad R Dabrowski1,2, Stephanie E Daws3,4

  • 1Center for Substance Abuse Research, Temple University, Philadelphia, PA, USA.

Molecular Neurobiology
|May 23, 2024
PubMed
Summary

Opioid use alters RNA methylation (m6A) in the brain, potentially through the AlkB Homolog 5 (Alkbh5) enzyme. This study reveals morphine-induced epitranscriptomic changes, offering new insights into opioid use disorder mechanisms.

Keywords:
Alkbh5MorphineN6-methyladenosineNeuronsOpioidsRNAm6A

More Related Videos

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method
10:53

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method

Published on: February 26, 2018

46.3K
Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression
10:54

Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression

Published on: February 10, 2017

9.4K

Related Experiment Videos

Last Updated: Jun 25, 2025

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.2K
Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method
10:53

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method

Published on: February 26, 2018

46.3K
Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression
10:54

Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression

Published on: February 10, 2017

9.4K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Epigenetics

Background:

  • Opioid overdose is a leading cause of accidental death, necessitating research into neurobiological consequences.
  • While opioid effects on the transcriptome and epigenome are known, epitranscriptomic regulation via RNA modifications is understudied.
  • N6-methyladenosine (m6A) RNA methylation is prevalent in the brain and crucial for cognitive functions, yet its role in opioid use disorder remains unexplored.

Purpose of the Study:

  • To investigate the role of m6A RNA modifications in the context of opioid use disorder.
  • To determine if chronic opioid exposure, specifically morphine, alters m6A-modifying enzymes in the brain.
  • To test the hypothesis that morphine regulates m6A modifications through modulation of the m6A demethylase AlkB Homolog 5 (Alkbh5).

Main Methods:

  • Primary rat cortical cultures were treated with morphine to assess changes in m6A-modifying enzymes.
  • Alkylation Homolog 5 (Alkbh5) enzyme activity was modulated via knockdown.
  • m6A RNA modification profiles were compared between morphine-treated cultures and those with Alkbh5 knockdown.

Main Results:

  • Morphine treatment significantly regulated m6A-modifying enzymes, including Alkbh5, in cortical cultures.
  • Morphine treatment and Alkbh5 knockdown resulted in concordant m6A epitranscriptomic profiles for a subset of transcripts.
  • Commonly regulated transcripts were associated with key neuronal functions such as serotonin secretion, synapse disassembly, neuron remodeling, and immune response.

Conclusions:

  • Morphine exposure induces significant epitranscriptomic changes in the brain.
  • A portion of these morphine-driven m6A modifications may be mediated by the downregulation of Alkbh5.
  • These findings highlight the potential role of epitranscriptomic alterations in opioid use disorder and suggest Alkbh5 as a target for future research.